Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Post Herpetic Neuralgia Therapies Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Post Herpetic Neuralgia Therapies Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Drugs
    • 1.4.3 Patches
    • 1.4.4 Steroid Injectable
  • 1.5 Market by Application
    • 1.5.1 Global Post Herpetic Neuralgia Therapies Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Online Pharmacies
    • 1.5.4 Retail Pharmacies
  • 1.6 Coronavirus Disease 2019 (Covid-19): Post Herpetic Neuralgia Therapies Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Post Herpetic Neuralgia Therapies Industry
      • 1.6.1.1 Post Herpetic Neuralgia Therapies Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Post Herpetic Neuralgia Therapies Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Post Herpetic Neuralgia Therapies Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Post Herpetic Neuralgia Therapies Market Perspective (2015-2026)
  • 2.2 Post Herpetic Neuralgia Therapies Growth Trends by Regions
    • 2.2.1 Post Herpetic Neuralgia Therapies Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Post Herpetic Neuralgia Therapies Historic Market Share by Regions (2015-2020)
    • 2.2.3 Post Herpetic Neuralgia Therapies Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Post Herpetic Neuralgia Therapies Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Post Herpetic Neuralgia Therapies Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Post Herpetic Neuralgia Therapies Players by Market Size
    • 3.1.1 Global Top Post Herpetic Neuralgia Therapies Players by Revenue (2015-2020)
    • 3.1.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Post Herpetic Neuralgia Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio
    • 3.2.1 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Post Herpetic Neuralgia Therapies Revenue in 2019
  • 3.3 Post Herpetic Neuralgia Therapies Key Players Head office and Area Served
  • 3.4 Key Players Post Herpetic Neuralgia Therapies Product Solution and Service
  • 3.5 Date of Enter into Post Herpetic Neuralgia Therapies Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Post Herpetic Neuralgia Therapies Historic Market Size by Type (2015-2020)
  • 4.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Type (2021-2026)

5 Post Herpetic Neuralgia Therapies Breakdown Data by Application (2015-2026)

  • 5.1 Global Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)
  • 5.2 Global Post Herpetic Neuralgia Therapies Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Post Herpetic Neuralgia Therapies Market Size (2015-2020)
  • 6.2 Post Herpetic Neuralgia Therapies Key Players in North America (2019-2020)
  • 6.3 North America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
  • 6.4 North America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Post Herpetic Neuralgia Therapies Market Size (2015-2020)
  • 7.2 Post Herpetic Neuralgia Therapies Key Players in Europe (2019-2020)
  • 7.3 Europe Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
  • 7.4 Europe Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)

8 China

  • 8.1 China Post Herpetic Neuralgia Therapies Market Size (2015-2020)
  • 8.2 Post Herpetic Neuralgia Therapies Key Players in China (2019-2020)
  • 8.3 China Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
  • 8.4 China Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Post Herpetic Neuralgia Therapies Market Size (2015-2020)
  • 9.2 Post Herpetic Neuralgia Therapies Key Players in Japan (2019-2020)
  • 9.3 Japan Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
  • 9.4 Japan Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Post Herpetic Neuralgia Therapies Market Size (2015-2020)
  • 10.2 Post Herpetic Neuralgia Therapies Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)

11 India

  • 11.1 India Post Herpetic Neuralgia Therapies Market Size (2015-2020)
  • 11.2 Post Herpetic Neuralgia Therapies Key Players in India (2019-2020)
  • 11.3 India Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
  • 11.4 India Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Post Herpetic Neuralgia Therapies Market Size (2015-2020)
  • 12.2 Post Herpetic Neuralgia Therapies Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Post Herpetic Neuralgia Therapies Market Size by Type (2015-2020)
  • 12.4 Central & South America Post Herpetic Neuralgia Therapies Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Endo Pharmaceuticals
    • 13.1.1 Endo Pharmaceuticals Company Details
    • 13.1.2 Endo Pharmaceuticals Business Overview and Its Total Revenue
    • 13.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Introduction
    • 13.1.4 Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020))
    • 13.1.5 Endo Pharmaceuticals Recent Development
  • 13.2 Depomed
    • 13.2.1 Depomed Company Details
    • 13.2.2 Depomed Business Overview and Its Total Revenue
    • 13.2.3 Depomed Post Herpetic Neuralgia Therapies Introduction
    • 13.2.4 Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
    • 13.2.5 Depomed Recent Development
  • 13.3 Acorda Therapeutics
    • 13.3.1 Acorda Therapeutics Company Details
    • 13.3.2 Acorda Therapeutics Business Overview and Its Total Revenue
    • 13.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Introduction
    • 13.3.4 Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
    • 13.3.5 Acorda Therapeutics Recent Development
  • 13.4 Pfizer
    • 13.4.1 Pfizer Company Details
    • 13.4.2 Pfizer Business Overview and Its Total Revenue
    • 13.4.3 Pfizer Post Herpetic Neuralgia Therapies Introduction
    • 13.4.4 Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
    • 13.4.5 Pfizer Recent Development
  • 13.5 Mylan
    • 13.5.1 Mylan Company Details
    • 13.5.2 Mylan Business Overview and Its Total Revenue
    • 13.5.3 Mylan Post Herpetic Neuralgia Therapies Introduction
    • 13.5.4 Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
    • 13.5.5 Mylan Recent Development
  • 13.6 Daiichi Sankyo
    • 13.6.1 Daiichi Sankyo Company Details
    • 13.6.2 Daiichi Sankyo Business Overview and Its Total Revenue
    • 13.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Introduction
    • 13.6.4 Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
    • 13.6.5 Daiichi Sankyo Recent Development
  • 13.7 Teikoku Pharma
    • 13.7.1 Teikoku Pharma Company Details
    • 13.7.2 Teikoku Pharma Business Overview and Its Total Revenue
    • 13.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Introduction
    • 13.7.4 Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2015-2020)
    • 13.7.5 Teikoku Pharma Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Post Herpetic Neuralgia Therapies market in 2020.
    COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
    The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyses the impact of Coronavirus COVID-19 on the Post Herpetic Neuralgia Therapies industry.
    Based on our recent survey, we have several different scenarios about the Post Herpetic Neuralgia Therapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Post Herpetic Neuralgia Therapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post Herpetic Neuralgia Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post Herpetic Neuralgia Therapies market in terms of revenue.
    Players, stakeholders, and other participants in the global Post Herpetic Neuralgia Therapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
    Regional and Country-level Analysis
    The report offers an exhaustive geographical analysis of the global Post Herpetic Neuralgia Therapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
    Competition Analysis
    In the competitive analysis section of the report, leading as well as prominent players of the global Post Herpetic Neuralgia Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post Herpetic Neuralgia Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post Herpetic Neuralgia Therapies market.
    The following players are covered in this report:
    Endo Pharmaceuticals
    Depomed
    Acorda Therapeutics
    Pfizer
    Mylan
    Daiichi Sankyo
    Teikoku Pharma
    ...
    Post Herpetic Neuralgia Therapies Breakdown Data by Type
    Drugs
    Patches
    Steroid Injectable
    Post Herpetic Neuralgia Therapies Breakdown Data by Application
    Hospital Pharmacies
    Online Pharmacies
    Retail Pharmacies

    Buy now